MRK vs LH
By Alex · Tickerpine
Merck & Co., Inc. vs Labcorp Holdings Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | LH |
|---|---|---|
| Price | $147.76 | $370.48 |
| Market cap | $364.26B | $30.08B |
| P/E ratio | 149.3 | 30.4 |
| ROE | 5.06% | 11.44% |
| Profit margin | 3.64% | 6.88% |
| Revenue growth | 4.70% | 6.90% |
| Dividend yield | 2.30% | 0.78% |
| Beta | 0.12 | 0.83 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs LH in plain English
- MRK is the bigger company — about 12.1× the market cap of LH.
- LH is cheaper on earnings (P/E 30.4 vs 149.3).
- LH earns a higher return on equity (11% vs 5%).
- LH is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.30% vs 0.78%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
LH return calculator
See what $1,000 in Labcorp Holdings Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.